Investigation Report on China ribonucleic acid II (RNAII) for Injection [2010-2019] - PowerPoint PPT Presentation

About This Presentation
Title:

Investigation Report on China ribonucleic acid II (RNAII) for Injection [2010-2019]

Description:

Marketreportsonchina.com presents a report on “Investigation Report on China ribonucleic acid II (RNAII) for Injection [2010-2019]”. RNAII for injection can also be used for the treatment of various diseases caused by low immune function. – PowerPoint PPT presentation

Number of Views:22

less

Transcript and Presenter's Notes

Title: Investigation Report on China ribonucleic acid II (RNAII) for Injection [2010-2019]


1
Investigation Report on China ribonucleic acid II
(RNAII) for Injection 2010-2019
Market Reports On China
http//www.marketreportsonchina.com
2
Summary
RNAII for injection, one kind of immunomodulator,
can improve body immunity and inhibit tumor by
causing vacuolar degeneration and colliquative
necrosis in tumor cells as well as generating
large amounts of hyperplastic fibroblasts,
macrophages, lymphocytes or even connective
tissue to substitute tumor tissue. And it is used
for the adjuvant treatment of pancreatic cancer,
liver cancer, stomach cancer, breast cancer, soft
tissue sarcoma and other cancers especially
hepatitis B. RNAII for injection can also be used
for the treatment of various diseases caused by
low immune function.
Scope The report provides in-depth market
analysis, information and insights, including
? A detailed coverage of the travel and
tourism industry in China ? A comprehensive
analysis of the airlines market in China ?
Profile of the top airlines operating in China

3
According to market survey, RNAII for injection
develops fast in China with sales value rising
from less than CNY 60 million in 2005 to about
CNY 500 million in 2014 and CAGR during this
period reaching 80. With the lifestyle changes
brought about by economic development as well as
the serious environmental pollution, the
incidence of cancer keeps increasing with the
number of new cases exceeding 3 million each year
in China. Meanwhile, there are over 90 million
hepatitis B patients in China too. Therefore, the
market size of RNAII for injection is expected to
keep growing in the next few years in
China.

4
Readers can get at least the following
information from this report -market size of
RNAII for injection in China -competitive
landscape of RNAII for injection in Chinese
market -price of RNAII for injection made by
different enterprises in China -market outlook of
RNAII for injection in China

5
The author suggests the following groups of
people purchase this report -manufacturers of
immunomodulator -investors/ research institutions
interested in Chinese medicine market -any
interest in the Chinese medicine market, please
contact for customized survey service

6
Table Of Content
1 Related Concepts of RNAII for Injection 2
Market Profile of RNAII for Injection in China 3
Survey on Sales Status of RNAII for Injection in
China, 2010-2014 4 Survey on Market Share of
Major Manufacturers of RNAII for Injection in
China, 2010-2014 5 Survey on Dosage Forms of
RNAII for Injection in China, 2010-2014 6
Reference Price of RNAII for Injection in Chinese
Hospitals in 2014 7 Major Manufacturers of RNAII
for Injection in Chinese Market, 2010-2014 8
Market Outlook of RNAII for Injection in China,
2015-2019

7
To view the full Executive Summary and Table of
Contents, please visit Investigation Report
on China ribonucleic acid II (RNAII) for
Injection 2010-2019 Contact Us Market
Reports On ChinaContact No 91 2227810772,
27810773 Email id info_at_marketreportsonchina.co
m Website http//marketreportsonchina.com/
Write a Comment
User Comments (0)
About PowerShow.com